IPA
Market cap | $50.80 Million |
---|---|
Enterprise Value | $53.37 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-1.06 |
Beta | 0.22 |
Outstanding Shares | 32,851,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -1.08 |
---|---|
PEG | -0.17 |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | 2.22 |
Enterprise Value to EBIT | -1.5 |
Enterprise Value to Net Income | -2 |
Total Debt to Enterprise | 0.29 |
Debt to Equity | 0.62 |
No data
No data
IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The...